Balthaser Kevin

Aclaris Therapeutics, Inc. ยท Chief Financial Officer

Balthaser Kevin is listed in public filings as officer: Chief Financial Officer. This Balthaser Kevin insider trading page organizes Form 4 disclosures, reported purchases and sales, transaction dates, share amounts, related issuers, and historical insider activity so readers can review the person's public trading record in one place. Companies and tickers connected to this insider trading profile include Aclaris Therapeutics, Inc. (ACRS). Investors use Balthaser Kevin's insider trading disclosures to study buying and selling patterns, position changes, company-specific activity, and the source evidence behind each reported transaction.

Latest Actions

CompanyHolding ValueLast TransactionAmountTransaction PriceCurrent Price
Aclaris Therapeutics, Inc.ACRS$538k187.5k sharesGrant / ExerciseMar 1, 2026$1.9K677 shares$2.87--
Aclaris Therapeutics, Inc.ACRS--2.4k sharesGrant / ExerciseMar 1, 2026Disclosure amount unavailable2.4k shares----

Insider Trades History

CompanyHolding ValueLast TransactionAmountTransaction PriceCurrent Price
Aclaris Therapeutics, Inc.ACRS--66.1k sharesGrant / ExerciseFeb 3, 2026Disclosure amount unavailable22k shares----
Aclaris Therapeutics, Inc.ACRS$645k185.8k sharesGrant / ExerciseFeb 3, 2026$22.4K6.4k shares$3.47--
Aclaris Therapeutics, Inc.ACRS$1.3M346.8k sharesGrant / ExerciseFeb 2, 2026$1.3M346.8k shares$3.61--
Aclaris Therapeutics, Inc.ACRS--99.1k sharesGrant / ExerciseFeb 2, 2026Disclosure amount unavailable99.1k shares----
Aclaris Therapeutics, Inc.ACRS--29.5k sharesGrant / ExerciseFeb 1, 2026Disclosure amount unavailable14.8k shares----
Aclaris Therapeutics, Inc.ACRS$597k170.2k sharesGrant / ExerciseFeb 1, 2026$17.5K5k shares$3.51--
Aclaris Therapeutics, Inc.ACRS--13.6k sharesGrant / ExerciseJan 2, 2026Disclosure amount unavailable13.2k shares----
Aclaris Therapeutics, Inc.ACRS$462k160.4k sharesGrant / ExerciseJan 2, 2026$12.8K4.5k shares$2.88--
Aclaris Therapeutics, Inc.ACRS--7.5k sharesGrant / ExerciseJan 1, 2026Disclosure amount unavailable7.5k shares----
Aclaris Therapeutics, Inc.ACRS$457k151.7k sharesGrant / ExerciseJan 1, 2026$6.8K2.3k shares$3.01--
Aclaris Therapeutics, Inc.ACRS--73.8k sharesGrant / ExerciseDec 31, 2025Disclosure amount unavailable73.8k shares----
Aclaris Therapeutics, Inc.ACRS$441k146.4k sharesGrant / ExerciseDec 31, 2025$60.0K19.9k shares$3.01--
Aclaris Therapeutics, Inc.ACRS$184k92.6k sharesGrant / ExerciseMar 1, 2025$1.4K727 shares$1.99--
Aclaris Therapeutics, Inc.ACRS--1.1k sharesGrant / ExerciseMar 1, 2025Disclosure amount unavailable1.1k shares----
Aclaris Therapeutics, Inc.ACRS--2.4k sharesGrant / ExerciseMar 1, 2025Disclosure amount unavailable2.4k shares----
Aclaris Therapeutics, Inc.ACRS$740k308.2k sharesGrant / ExerciseFeb 3, 2025$739.7K308.2k shares$2.40--
Aclaris Therapeutics, Inc.ACRS--88.1k sharesGrant / ExerciseFeb 3, 2025Disclosure amount unavailable88.1k shares----
Aclaris Therapeutics, Inc.ACRS--44.3k sharesGrant / ExerciseFeb 1, 2025Disclosure amount unavailable14.8k shares----
Aclaris Therapeutics, Inc.ACRS$223k89.9k sharesGrant / ExerciseFeb 1, 2025$14.4K5.8k shares$2.48--
Aclaris Therapeutics, Inc.ACRS--26.8k sharesGrant / ExerciseJan 2, 2025Disclosure amount unavailable13.2k shares----
Aclaris Therapeutics, Inc.ACRS--40k sharesGrant / ExerciseJan 2, 2025Disclosure amount unavailable40k shares----
Aclaris Therapeutics, Inc.ACRS$201k80.9k sharesGrant / ExerciseJan 2, 2025$12.5K5.1k shares$2.48--
Aclaris Therapeutics, Inc.ACRS--15k sharesGrant / ExerciseJan 1, 2025Disclosure amount unavailable7.5k shares----
Aclaris Therapeutics, Inc.ACRS$181k72.8k sharesGrant / ExerciseJan 1, 2025$6.0K2.4k shares$2.48--
Aclaris Therapeutics, Inc.ACRS--73.8k sharesGrant / ExerciseDec 31, 2024Disclosure amount unavailable73.8k shares----
Aclaris Therapeutics, Inc.ACRS$168k67.7k sharesGrant / ExerciseDec 31, 2024$76.2K30.7k shares$2.48--
Aclaris Therapeutics, Inc.ACRS$29k24.7k sharesGrant / ExerciseSep 1, 2024$337286 shares$1.18--
Aclaris Therapeutics, Inc.ACRS--1k sharesGrant / ExerciseSep 1, 2024Disclosure amount unavailable1k shares----